Tempest Therapeutics TPST
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 10.28 | 102.42 | -0.54 | -3,596 | -4 | |
| 2025Q2 | 6.80 | 101.81 | -2.01 | -7,966 | -8 | |
| 2025Q1 | 9.59 | 102.22 | -3.16 | -10,936 | -11 | |
| 2024Q4 | 10.85 | 102.59 | -4.02 | -13,918 | -14 | |
| 2024Q3 | 18.20 | 103.18 | -5.33 | -10,552 | -11 | |
| 2024Q2 | 28.47 | 104.17 | -5.53 | -9,582 | -10 | |
| 2024Q1 | 50.83 | 105.81 | -4.62 | -7,974 | -8 | |
| 2023Q4 | 57.20 | 105.67 | -4.42 | -7,514 | -7 | |
| 2023Q3 | 3.96 | 102.79 | -6.24 | -6,592 | -7 | |
| 2023Q2 | 16.51 | 103.38 | -7.02 | -7,470 | -8 | |
| 2023Q1 | 30.16 | 103.96 | -7.15 | -7,581 | -8 | |
| 2022Q4 | 14.95 | 103.03 | -8.19 | -8,934 | -9 | |
| 2022Q3 | 22.62 | 102.49 | -7.54 | -8,771 | -9 | |
| 2022Q2 | 27.95 | 100.80 | -9.10 | -8,774 | -9 | |
| 2022Q1 | 43.94 | 100.04 | -15.34 | -8,161 | -8 | |
| 2021Q4 | 68.64 | 98.62 | 0.26 | -7,338 | -8 | |
| 2021Q3 | 188.11 | 100.82 | 127.53 | -7,736 | -8 | |
| 2021Q2 | 145.34 | 100.04 | -87.75 | -6,785 | -7 | |
| 2021Q1 | 102.07 | -137.15 | -8,562 | -8 | ||
| 2020Q4 | 97.58 | -118.56 | -20,997 | -22 |